Categories
Press Releases and Statements

TransActual statement on launch of puberty blocker trial

Embargoed until 0001, 22 November 2025 Following the announcement that two new research studies PATHWAYS TRIAL and PATHWAYS CONNECT have received the necessary regulatory and ethics approval to proceed as […]

Skip to content